Oculoplastic Surgery
The FDA has approved veligrotug-vvze (Lumvoa; Viridian Therapeutics, Waltham, MA, USA) for the treatment of thyroid eye disease (TED), regardless of disease activity or duration.
This week in ophthalmology: expert pearls on posterior capsule opacification after cataract surgery, new clinical data for MHB018A in thyroid eye disease, uncontrolled blood pressure in patients with diabetes attending retina care, practical B-scan ultrasound guidance for retina clinics, and the opening of the 40th World Ophthalmology Congress in Prague. Here are five stories to catch up on this week.
Updated Phase I/II data presented at ENDO 2026 suggest subcutaneous MHB018A was associated with proptosis and diplopia responses in patients with active and chronic thyroid eye disease.
Designed for busy clinicians, these short, focused articles cut through theory to highlight what truly matters at the point of care including what works, what to watch for, and how to optimise outcomes in real-world settings.
Each January, the global ophthalmology community heads to the Big Island to kick off the year with new ideas, clinical insights and forward-looking discussions, and Hawaiian Eye and Retina 2026 is already delivering on that promise.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.
We were delighted to speak with Dr Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA) about advances in treatment options for patients with thyroid eye disease. Questions: Â Â What have been the most important recent treatment advances in thyroid eye ...
It was a pleasure to catch up with Dr Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA), who talked us through the latest updates in thyroid eye disease and the reasons it is so often misdiagnosed. Questions: Â Â Could you ...
Blepharoptosis is a common complication following eye removal.1Â Blepharoptosis in acquired anophthalmia can exacerbate a pre-existing sense of facial deformity and dissatisfaction.2Â In many patients, a favourable cosmetic outcome can be achieved without further surgery. Augmentation of the superior aspect ...
It was a pleasure to speak with Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA) about his work on brow ptosis, and the pros and cons of the surgical techniques for brow ptosis. Questions What are the causes of ...
Trichofolliculoma is a rare, benign skin tumour arising from a hair follicle containing a large central cystic hair follicle with branching epithelial strands and buds.1–5 Trichofolliculomas typically affect the head and neck, appear flesh-coloured, dome-shaped, and may also have a ...
Orbital inflammation can result from a number of inflammatory conditions including dacryoadenitis, myositis, cellulitis, optic perineuritis, periscleritis, orbital apicitis, thyroid eye disease (TED), and a focal mass.1 It may present as acute, subacute, or chronic disease and has a wide ...
Clare Quigley shares her experiences as a member of the YO committee and talks about the key challenges of training in surgery. Questions: 1. What are the main challenges facing YOs in 2019? (0:04) 2. What are the key challenges of training in surgery? (1:14) 3. ...
Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The ...
Enucleation, or surgical removal of the entire eye globe, was described by Bartisch in 1583, and was described in combination with orbital volume replacement (implant) by Mules in 1585.1–3 In the US, trauma is the leading indication for enucleation (40.9% of cases), followed ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
